Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results

BACKGROUND: The STAR-TReC trial is an international multi-center, randomized, phase II study assessing the feasibility of short-course radiotherapy or long-course chemoradiotherapy as an alternative to total mesorectal excision surgery. A new target volume is used for both (chemo)radiotherapy arms w...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Ende, Roy P. J., Peters, Femke P., Harderwijk, Ernst, Rütten, Heidi, Bouwmans, Liza, Berbee, Maaike, Canters, Richard A. M., Stoian, Georgiana, Compagner, Kim, Rozema, Tom, de Smet, Mariska, Intven, Martijn P. W., Tijssen, Rob H. N., Theuws, Jacqueline, van Haaren, Paul, van Triest, Baukelien, Eekhout, Dave, Marijnen, Corrie A. M., van der Heide, Uulke A., Kerkhof, Ellen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027245/
https://www.ncbi.nlm.nih.gov/pubmed/32070386
http://dx.doi.org/10.1186/s13014-020-01487-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027245/
https://www.ncbi.nlm.nih.gov/pubmed/32070386
http://dx.doi.org/10.1186/s13014-020-01487-6

Ejemplares similares